1 | 1 | | |
---|
2 | 2 | | |
---|
3 | 3 | | EXPLANATION: CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW. |
---|
4 | 4 | | [Brackets] indicate matter deleted from existing law. |
---|
5 | 5 | | *hb1489* |
---|
6 | 6 | | |
---|
7 | 7 | | HOUSE BILL 1489 |
---|
8 | 8 | | J1 5lr3525 |
---|
9 | 9 | | HB 986/24 – HGO CF SB 876 |
---|
10 | 10 | | By: Delegates Martinez, Alston, and Turner |
---|
11 | 11 | | Introduced and read first time: February 12, 2025 |
---|
12 | 12 | | Assigned to: Rules and Executive Nominations |
---|
13 | 13 | | |
---|
14 | 14 | | A BILL ENTITLED |
---|
15 | 15 | | |
---|
16 | 16 | | AN ACT concerning 1 |
---|
17 | 17 | | |
---|
18 | 18 | | Maryland Medical Assistance Program – Coverage for the Treatment of Obesity 2 |
---|
19 | 19 | | |
---|
20 | 20 | | FOR the purpose of requiring, beginning on a certain date, the Maryland Medical 3 |
---|
21 | 21 | | Assistance Program to provide comprehensive coverage for the treatment of obesity; 4 |
---|
22 | 22 | | requiring the Maryland Department of Health to provide notice to Program 5 |
---|
23 | 23 | | recipients of the coverage requirements; and generally relating to the Maryland 6 |
---|
24 | 24 | | Medical Assistance Program and coverage for the treatment of obesity. 7 |
---|
25 | 25 | | |
---|
26 | 26 | | BY repealing and reenacting, without amendments, 8 |
---|
27 | 27 | | Article – Health – General 9 |
---|
28 | 28 | | Section 15–103(a)(1) 10 |
---|
29 | 29 | | Annotated Code of Maryland 11 |
---|
30 | 30 | | (2023 Replacement Volume and 2024 Supplement) 12 |
---|
31 | 31 | | |
---|
32 | 32 | | BY repealing and reenacting, with amendments, 13 |
---|
33 | 33 | | Article – Health – General 14 |
---|
34 | 34 | | Section 15–103(a)(2)(xxiii) and (xxiv) 15 |
---|
35 | 35 | | Annotated Code of Maryland 16 |
---|
36 | 36 | | (2023 Replacement Volume and 2024 Supplement) 17 |
---|
37 | 37 | | |
---|
38 | 38 | | BY adding to 18 |
---|
39 | 39 | | Article – Health – General 19 |
---|
40 | 40 | | Section 15–103(a)(2)(xxv) and 15–157 20 |
---|
41 | 41 | | Annotated Code of Maryland 21 |
---|
42 | 42 | | (2023 Replacement Volume and 2024 Supplement) 22 |
---|
43 | 43 | | |
---|
44 | 44 | | SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 23 |
---|
45 | 45 | | That the Laws of Maryland read as follows: 24 |
---|
46 | 46 | | |
---|
47 | 47 | | Article – Health – General 25 |
---|
48 | 48 | | 2 HOUSE BILL 1489 |
---|
49 | 49 | | |
---|
50 | 50 | | |
---|
51 | 51 | | 15–103. 1 |
---|
52 | 52 | | |
---|
53 | 53 | | (a) (1) The Secretary shall administer the Maryland Medical Assistance 2 |
---|
54 | 54 | | Program. 3 |
---|
55 | 55 | | |
---|
56 | 56 | | (2) The Program: 4 |
---|
57 | 57 | | |
---|
58 | 58 | | (xxiii) Beginning on July 1, 2025, shall provide, subject to the 5 |
---|
59 | 59 | | limitations of the State budget, and as permitted by federal law, coverage for biomarker 6 |
---|
60 | 60 | | testing in accordance with § 15–859 of the Insurance Article; [and] 7 |
---|
61 | 61 | | |
---|
62 | 62 | | (xxiv) Beginning on January 1, 2025, shall provide coverage for 8 |
---|
63 | 63 | | prostheses in accordance with § 15–844 of the Insurance Article; AND 9 |
---|
64 | 64 | | |
---|
65 | 65 | | (XXV) BEGINNING ON JULY 1, 2026, SHALL PROVIDE 10 |
---|
66 | 66 | | COMPREHENSIVE COVERA GE FOR THE TREATMENT OF OBESITY IN ACCORD ANCE 11 |
---|
67 | 67 | | WITH § 15–157 OF THIS SUBTITLE . 12 |
---|
68 | 68 | | |
---|
69 | 69 | | 15–157. 13 |
---|
70 | 70 | | |
---|
71 | 71 | | (A) (1) IN THIS SECTION THE F OLLOWING WORDS HAVE THE MEANINGS 14 |
---|
72 | 72 | | INDICATED. 15 |
---|
73 | 73 | | |
---|
74 | 74 | | (2) “COMPREHENSIVE COVERAG E FOR THE TREATMENT OF OBESITY” 16 |
---|
75 | 75 | | INCLUDES COVERAGE FO R INTENSIVE BEHAVIOR AL THERAPY, BARIATRIC SURGERY , 17 |
---|
76 | 76 | | AND FDA–APPROVED ANTI–OBESITY MEDICATION . 18 |
---|
77 | 77 | | |
---|
78 | 78 | | (3) “FDA–APPROVED ANTI –OBESITY MEDICATION ” MEANS ANY 19 |
---|
79 | 79 | | MEDICATION APPROVED BY THE FEDERAL FOOD AND DRUG ADMINISTRATION WITH 20 |
---|
80 | 80 | | AN INDICATION FOR CH RONIC WEIGHT MANAGEM ENT IN PATIENTS WITH OBESITY. 21 |
---|
81 | 81 | | |
---|
82 | 82 | | (B) THE PROGRAM SHALL PROVI DE COMPREHENSIVE COV ERAGE FOR THE 22 |
---|
83 | 83 | | TREATMENT OF OBESITY . 23 |
---|
84 | 84 | | |
---|
85 | 85 | | (C) COVERAGE CRITERIA FOR FDA–APPROVED ANTI –OBESITY 24 |
---|
86 | 86 | | MEDICATIONS PROVIDED UNDER THIS SECTION M AY NOT BE MORE RESTR ICTIVE 25 |
---|
87 | 87 | | THAN THE FDA–APPROVED ANTI –OBESITY MEDICATION ’S INDICATIONS FOR 26 |
---|
88 | 88 | | TREATMENT . 27 |
---|
89 | 89 | | |
---|
90 | 90 | | (D) THE PROGRAM MAY UNDERTAKE UTILIZATION MANAGEME NT TO 28 |
---|
91 | 91 | | DETERMINE THE MEDICA L NECESSITY AND APPR OPRIATENESS FOR TREA TMENT OF 29 |
---|
92 | 92 | | OBESITY UNDER THIS S ECTION IF THE DETERM INATIONS ARE MADE IN THE SAME 30 |
---|
93 | 93 | | MANNER AS DETERMINAT IONS ARE MADE FOR TH E TREATMENT OF ANY O THER 31 |
---|
94 | 94 | | ILLNESS, CONDITION, OR DISORDER COVERED BY THE PROGRAM. 32 HOUSE BILL 1489 3 |
---|
95 | 95 | | |
---|
96 | 96 | | |
---|
97 | 97 | | |
---|
98 | 98 | | (E) THE DEPARTMENT SHALL PROV IDE NOTICE TO PROGRAM RECIPIENTS 1 |
---|
99 | 99 | | OF THE COVERAGE REQU IRED UNDER THIS SECT ION. 2 |
---|
100 | 100 | | |
---|
101 | 101 | | SECTION 2. AND BE IT FURTHER ENACTED, That, on or before June 1, 2026, 3 |
---|
102 | 102 | | the Maryland Department of Health shall provide notice to Maryland Medical Assistance 4 |
---|
103 | 103 | | Program recipients of the coverage required by this Act in writing, and prominently 5 |
---|
104 | 104 | | positioned in any literature or correspondence sent to Program recipients about coverage 6 |
---|
105 | 105 | | available under the Program in calendar year 2026. 7 |
---|
106 | 106 | | |
---|
107 | 107 | | SECTION 3. AND BE IT FURTHER ENACTED, That this Act shall take effect 8 |
---|
108 | 108 | | October 1, 2025. 9 |
---|